{"id":6700,"date":"2025-05-10T13:00:13","date_gmt":"2025-05-10T13:00:13","guid":{"rendered":"https:\/\/autism.fratnow.com\/blog\/?p=6700"},"modified":"2025-05-10T13:37:04","modified_gmt":"2025-05-10T13:37:04","slug":"the-connection-between-fraas-frat-and-folinic-acid","status":"publish","type":"post","link":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/","title":{"rendered":"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid"},"content":{"rendered":"<p>[vc_row][vc_column][vc_single_image image=&#8221;6701&#8243; img_size=&#8221;full&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;Folate Receptor Autoantibodies (FRAAs)&#8221;][vc_column_text single_style=&#8221;&#8221;]<a href=\"https:\/\/autism.fratnow.com\/blog\/folate-receptor-autoantibodies-in-families-with-autistic-individuals\/\" target=\"_blank\" rel=\"noopener\">Folate receptor autoantibodies (FRAAs)<\/a> represent a groundbreaking discovery in neurodevelopmental and neuropsychiatric medicine. These autoantibodies target the folate receptor alpha (FR\u03b1), a critical protein responsible for transporting folate <a href=\"https:\/\/autism.fratnow.com\/blog\/importance-of-vitamin-b9-folate-for-better-brain-development-in-fetuses\/\" target=\"_blank\" rel=\"noopener\">(vitamin B9)<\/a> across the blood-brain barrier and into various tissues throughout the body. When these autoantibodies are present, they interfere with folate transport, potentially leading to <a href=\"https:\/\/autism.fratnow.com\/blog\/cerebral-folate-deficiency-an-overview\/\" target=\"_blank\" rel=\"noopener\">cerebral folate deficiency (CFD)<\/a> despite normal systemic folate levels.<\/p>\n<p>The clinical implications of FRAAs are profound, with research linking them to:[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]<\/p>\n<ul class=\"mr-left-ol-40-list mr-left-ul-40\">\n<li>Autism Spectrum Disorders (ASD)<\/li>\n<li>Cerebral Folate Deficiency Syndrome<\/li>\n<li>Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)<\/li>\n<li>Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)<\/li>\n<li>Depression and other mood disorders<\/li>\n<li>Schizophrenia<\/li>\n<li>Neural Tube Defects (NTDs)<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]Approximately 70-75% of children with ASD have been found to have these autoantibodies in numerous studies, suggesting a significant subgroup that may benefit from targeted treatment. The prevalence in <a href=\"https:\/\/autism.fratnow.com\/blog\/pans-pandas-symptoms-diagnosis-treatment-research\/\" target=\"_blank\" rel=\"noopener\">PANS\/PANDAS<\/a> populations is similarly high at about 63.8% 3.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;Understanding the FRAT<sup>\u00ae<\/sup> Test: Detection and Diagnosis&#8221;][vc_column_text single_style=&#8221;&#8221;]The <a href=\"https:\/\/www.fratnow.com\/\" target=\"_blank\" rel=\"noopener\">Folate Receptor Autoantibody Test (FRAT<sup>\u00ae<\/sup>)<\/a> is a specialized blood test designed to detect and quantify these problematic autoantibodies. This test represents a significant advancement over traditional diagnostic methods, which often required invasive lumbar punctures to measure cerebrospinal fluid (CSF) folate levels.[\/vc_column_text][vc_custom_heading text=&#8221;Key Features of the FRAT<sup>\u00ae<\/sup> Test:&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;][vc_column_text single_style=&#8221;&#8221;]<\/p>\n<ol class=\"mr-left-ul-40\">\n<li><strong>Dual Assay System:<\/strong> The test measures two distinct types of autoantibodies:\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li><em><strong>Blocking autoantibodies:<\/strong><\/em> These directly prevent folate from binding to the FR\u03b1 receptor<\/li>\n<li><em><strong>Binding autoantibodies:<\/strong><\/em> These alter the receptor&#8217;s configuration, impairing its function and causing an inflammatory response<\/li>\n<\/ul>\n<\/li>\n<li><strong>Clinical Utility:<\/strong> The test helps identify patients who may benefit from alternative folate therapies, particularly those with:\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li>Unexplained neurodevelopmental delays<\/li>\n<li>Treatment-resistant neuropsychiatric symptoms<\/li>\n<li>ASD with poor response to conventional therapies<\/li>\n<\/ul>\n<\/li>\n<li><strong>Testing Protocol:<\/strong>\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li>Requires a simple blood draw (1-4 mL of serum)<\/li>\n<li>No fasting required<\/li>\n<li>Patients should discontinue folinic acid or 5-MTHF supplements 48 hours prior to testing<\/li>\n<li>Results typically available in 2-4 weeks, which includes results for both blocking and binding autoantibodies<\/li>\n<\/ul>\n<\/li>\n<li><strong>Interpretation:<\/strong> Results are categorized with titer levels for each autoantibody type, guiding treatment decisions.<\/li>\n<\/ol>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]The correlation between serum FRAA levels and CSF folate concentrations has been validated in some previous studies, supporting the use of this less invasive testing method.<br \/>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;The Science Behind Folate Transport Disruption&#8221;][vc_column_text single_style=&#8221;&#8221;]To understand the clinical impact of FRAAs, it&#8217;s essential to grasp the normal folate transport mechanisms and how autoantibodies disrupt them:<br \/>\n[\/vc_column_text][vc_custom_heading text=&#8221;Normal Folate Physiology&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;][vc_column_text single_style=&#8221;&#8221;]<\/p>\n<ol class=\"mr-left-ol-40\">\n<li style=\"list-style-type: none;\">\n<ol class=\"mr-left-ol-40\">\n<li><strong>Folate Receptors:<\/strong> The body utilizes several folate transport systems:\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li><strong>Folate Receptor Alpha (FR\u03b1):<\/strong> High-affinity transporter active at low folate concentrations, primary transporter at blood-brain barrier<\/li>\n<li><strong>Reduced Folate Carrier (RFC):<\/strong> Lower affinity, bidirectional transporter active at higher folate concentrations<\/li>\n<li><strong>Proton-Coupled Folate Transporter (PCFT):<\/strong> Important for intestinal absorption<\/li>\n<\/ul>\n<\/li>\n<li><strong>Brain Folate Transport:<\/strong> FR\u03b1 on choroid plexus epithelial cells mediates folate transport into CSF through an endocytosis mechanism. This process is ATP-dependent and crucial for maintaining adequate 5-methyltetrahydrofolate (5-MTHF) levels in the central nervous system.<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p>[\/vc_column_text][vc_custom_heading text=&#8221;Autoantibody Mechanisms&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;][vc_column_text single_style=&#8221;&#8221;]FRAAs disrupt this delicate system through two primary mechanisms:<\/p>\n<ol class=\"mr-left-ul-40\">\n<li><strong>Blocking Antibodies:<\/strong> Bind directly to the folate binding site on FR\u03b1, physically preventing folate attachment<\/li>\n<li><strong>Binding Antibodies:<\/strong> Attach to other regions of FR\u03b1, causing conformational changes that impair receptor function or promote its degradation<\/li>\n<\/ol>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]This disruption leads to cerebral folate deficiency despite normal blood folate levels, creating a unique metabolic scenario where the brain is starved of this critical nutrient while the rest of the body has adequate supplies.<br \/>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;Clinical Manifestations of Folate Receptor Autoimmunity&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;][vc_column_text single_style=&#8221;&#8221;]The clinical presentation of FRAA-related disorders varies widely but often includes many neurodevelopmental symptoms, such as:<\/p>\n<ul class=\"mr-left-ul-40\">\n<li>Speech and language impairments (from delayed speech to complete mutism)<\/li>\n<li>Social communication difficulties<\/li>\n<li>Stereotyped behaviors<\/li>\n<li>Cognitive impairment<\/li>\n<li>Developmental regression<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]It also presents itself with other neurological symptoms, such as:<\/p>\n<ul class=\"mr-left-ul-40\">\n<li>Seizures<\/li>\n<li>Movement disorders (ataxia, dyskinesia)<\/li>\n<li>Sleep disturbances<\/li>\n<li>Hypotonia<\/li>\n<li>Visual disturbances 47<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]Additionally, other psychiatric symptoms may include:<\/p>\n<ul class=\"mr-left-ul-40\">\n<li>Anxiety<\/li>\n<li>Depression<\/li>\n<li>OCD-like behaviors<\/li>\n<li>Psychosis (in severe cases)<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]In PANS\/PANDAS patients, the presence of FRAAs was particularly associated with more severe tics. ASD patients with FRAAs often show a distinct symptom profile that may respond differently to conventional therapies.<br \/>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;Folinic Acid Treatment: Mechanism and Protocol&#8221;][vc_column_text single_style=&#8221;&#8221;]For patients testing positive on the FRAT<sup>\u00ae<\/sup> test, folinic acid (leucovorin calcium) has emerged as a promising treatment option. Unlike folic acid, folinic acid is a reduced, bioactive form of folate that can bypass the blocked FR\u03b1 system by utilizing alternative transport mechanisms.[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]Why Folinic Acid Works:<\/p>\n<ol class=\"mr-left-ul-40\">\n<li><strong>Alternative Transport:<\/strong> Can utilize the Reduced Folate Carrier (RFC) system, which isn&#8217;t affected by FR\u03b1 autoantibodies<\/li>\n<li><strong>Blood-Brain Barrier Penetration:<\/strong> Effectively crosses into the CNS even with FR\u03b1 dysfunction<\/li>\n<li><strong>Bioavailability:<\/strong> Doesn&#8217;t require complex activation steps like folic acid<\/li>\n<li><strong>Safety Profile:<\/strong> Generally well-tolerated with minimal side effects<\/li>\n<\/ol>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]<strong>Although NOT approved by the FDA<\/strong> to be used for children with Autism or other neurodevelopmental, neuropsychiatric disorder, some physicians have been prescribing it off label. Please visit this informational piece for further information.<br \/>\n<a href=\"https:\/\/www.cbsnews.com\/news\/autism-leucovorin-medicine-folic-acid\/\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.cbsnews.com\/news\/autism-leucovorin-medicine-folic-acid\/<\/a>[\/vc_column_text][vc_custom_heading text=&#8221;Treatment Protocol:&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;][vc_column_text single_style=&#8221;&#8221;]Typically, physicians using folinic acid off label acid have been generally adhering to the following:<\/p>\n<ol class=\"mr-left-ul-40\">\n<li><strong>Dosing:<\/strong>\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li><strong>Typical range:<\/strong> 0.5-2 mg\/kg\/day (max 50 mg\/day)<\/li>\n<li>Some cases benefit from higher doses (up to 5 mg\/kg\/day)<\/li>\n<li>Often administered in split doses (e.g., twice daily)<\/li>\n<\/ul>\n<\/li>\n<li><strong>Formulations:<\/strong>\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li>Pharmaceutical grade leucovorin (tablets that can be crushed)<\/li>\n<li>Compounded liquid preparations for those who can&#8217;t swallow pills<\/li>\n<li>Over-the-counter folinic acid supplements (lower potency)<\/li>\n<\/ul>\n<\/li>\n<li><strong>Monitoring:<\/strong>\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li>Clinical response should be evaluated after 3-6 months<\/li>\n<li>FRAT<sup>\u00ae<\/sup> can be repeated to monitor autoantibody levels<\/li>\n<li>Adjust dose based on response and side effects<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]This protocol has generally been adhered to based upon previous scientific literature and experience in treating children with ASD. Again, this is NOT FDA approved, and physician guidance and consultation is required, as it is being used as off-label. [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;Clinical Evidence Supporting Folinic Acid Treatment&#8221;][vc_column_text single_style=&#8221;&#8221;]Multiple studies have demonstrated the efficacy of folinic acid in FRAA-positive individuals:<br \/>\nASD Studies:<\/p>\n<ul class=\"mr-left-ul-40\">\n<li>A randomized controlled trial showed significant improvement in verbal communication, particularly in FRAA-positive children<\/li>\n<li>Open-label studies reported improvements in language, social interaction, attention, and behavior in about one-third of treated children<\/li>\n<li>Improvements often seen in core ASD symptoms like eye contact, social initiation, and repetitive behaviors<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]For further information on scientific literature, please visit <a href=\"https:\/\/www.fratnow.com\/publication.php\" target=\"_blank\" rel=\"noopener\">https:\/\/www.fratnow.com\/publication.php<\/a><br \/>\n[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]Beyond Autism, there have been some interesting findings in <strong>PANS\/PANDAS.<\/strong><\/p>\n<ul class=\"mr-left-ul-40\">\n<li>Case reports describe symptom improvement in FRAA-positive patients<\/li>\n<li>May complement standard antimicrobial and immunomodulatory therapies<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]The use of FRAT<sup>\u00ae<\/sup> has opened up a new paradigm of assessing folate transport, especially in those with neurodevelopmental and neuropsychiatric disorders. Some general observations have been:<\/p>\n<ul class=\"mr-left-ul-40\">\n<li>Earlier treatment initiation correlates with better outcomes<\/li>\n<li>Children with both blocking and binding antibodies may require higher doses<\/li>\n<li>Effects typically become noticeable within weeks to months<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;Comprehensive Treatment Approach&#8221;][vc_column_text single_style=&#8221;&#8221;]While folinic acid is central to managing FRAA-related disorders, optimal outcomes often require a multifaceted approach:<\/p>\n<ol class=\"mr-left-ul-40\">\n<li><strong>Dietary Modifications:<\/strong>\n<ul class=\"mr-left-ol-40-list mr-left-ul-40\">\n<li><strong>Dairy Elimination:<\/strong> Milk proteins may stimulate FRAA production. Strict avoidance of all animal milk (cow, goat, sheep) is recommended<\/li>\n<\/ul>\n<\/li>\n<li><strong> Cofactor Supplementation:<\/strong>\n<ul class=\"mr-left-ol-40-list mr-left-ul-40\">\n<li><strong>Vitamin D:<\/strong> May upregulate alternative folate transporters (RFC). Optimal levels: 60-80 ng\/mL 7<\/li>\n<li><strong>Methylcobalamin (B12):<\/strong> Works synergistically with folate in methylation cycles<\/li>\n<li><strong>Pyrroloquinoline Quinone (PQQ):<\/strong> May enhance RFC expression<\/li>\n<\/ul>\n<\/li>\n<li><strong>Adjunctive Therapies:<\/strong>\n<ul class=\"mr-left-ol-40-list mr-left-ul-40\">\n<li>Speech and occupational therapy<\/li>\n<li>Behavioral interventions<\/li>\n<li>Treatment of comorbid conditions<\/li>\n<\/ul>\n<\/li>\n<li><strong>Monitoring and Follow-up:<\/strong>\n<ul class=\"mr-left-ol-40-list mr-left-ul-40\">\n<li>Regular clinical assessments<\/li>\n<li>Periodic FRAT<sup>\u00ae<\/sup> testing to monitor autoantibody levels<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text single_style=&#8221;&#8221;]While the FRAT<sup>\u00ae<\/sup> test and folinic acid treatment represent significant advances, several areas require further exploration:<\/p>\n<ol class=\"mr-left-ul-40\">\n<li><strong>Standardization:<\/strong> Developing consensus guidelines for testing and treatment protocols<\/li>\n<li><strong>Long-term Outcomes:<\/strong> More data on extended treatment effects into adulthood<\/li>\n<li><strong>Combination Therapies:<\/strong> Optimizing adjunctive treatments (immunomodulation, diet are examples)<\/li>\n<li><strong>Prevention Strategies:<\/strong> Potential for early screening and intervention; this is critical<\/li>\n<li><strong>Basic Mechanisms:<\/strong> Further elucidation of autoantibody triggers and propagation<\/li>\n<\/ol>\n<p>[\/vc_column_text][vc_column_text single_style=&#8221;&#8221;]Ongoing research continues to refine our understanding of folate receptor autoimmunity and its management, offering hope for improved outcomes in affected individuals.<br \/>\n[\/vc_column_text][vc_custom_heading text=&#8221;Conclusion&#8221;][vc_column_text single_style=&#8221;&#8221;]The discovery of folate receptor autoantibodies and the development of the FRAT<sup>\u00ae<\/sup> test have revolutionized our approach to several neurodevelopmental and neuropsychiatric conditions. By identifying this specific pathophysiology, clinicians can now offer targeted treatment with folinic acid to a substantial subgroup of patients who may have previously been treatment-resistant.<\/p>\n<p>The clinical evidence, while still evolving, strongly supports the utility of this approach, particularly in ASD and related disorders. With proper identification through FRAT<sup>\u00ae<\/sup> testing and appropriate folinic acid treatment, many patients experience improvements in communication, behavior, and overall functioning that can be truly transformative.<\/p>\n<p>As awareness grows and research advances, this paradigm of testing and targeted treatment promises to benefit an increasing number of individuals affected by folate transport disorders, offering new hope where conventional therapies have fallen short![\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Discover how FRAAs, the FRAT<sup>\u00ae<\/sup> test, and folinic acid offer targeted hope for ASD, PANS\/PANDAS, and more through folate transport correction.<\/p>\n","protected":false},"author":1,"featured_media":6701,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[70],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Connection Between FRAAs, FRAT\u00ae and Folinic Acid<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid\" \/>\n<meta property=\"og:description\" content=\"Discover how FRAAs, the FRAT\u00ae test, and folinic acid offer targeted hope for ASD, PANS\/PANDAS, and more through folate transport correction.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/\" \/>\n<meta property=\"og:site_name\" content=\"fratnow.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/autismfrat\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-10T13:00:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-10T13:37:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/05\/the-connection-between-fraas-frat-and-folinic-acid-blog-listing-image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"730\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Steve Tsetsekos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid\" \/>\n<meta name=\"twitter:description\" content=\"Discover how FRAAs, the FRAT\u00ae test, and folinic acid offer targeted hope for ASD, PANS\/PANDAS, and more through folate transport correction.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/05\/the-connection-between-fraas-frat-and-folinic-acid-blog-listing-image.webp\" \/>\n<meta name=\"twitter:creator\" content=\"@AutismFrat\" \/>\n<meta name=\"twitter:site\" content=\"@AutismFrat\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Tsetsekos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/\"},\"author\":{\"name\":\"Steve Tsetsekos\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/f8b6a595b4790f970dfaa3517b804ef2\"},\"headline\":\"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid\",\"datePublished\":\"2025-05-10T13:00:13+00:00\",\"dateModified\":\"2025-05-10T13:37:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/\"},\"wordCount\":1800,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\"},\"articleSection\":[\"Neurodiversity &amp; Wellbeing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/\",\"name\":\"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid\",\"isPartOf\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#website\"},\"datePublished\":\"2025-05-10T13:00:13+00:00\",\"dateModified\":\"2025-05-10T13:37:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/autism.fratnow.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#website\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/\",\"name\":\"fratnow.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/autism.fratnow.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\",\"name\":\"fratnow.com\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png\",\"contentUrl\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png\",\"width\":194,\"height\":66,\"caption\":\"fratnow.com\"},\"image\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/autismfrat\",\"https:\/\/twitter.com\/AutismFrat\",\"https:\/\/www.linkedin.com\/company\/88011685\/admin\/\",\"https:\/\/www.instagram.com\/fratautism\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/f8b6a595b4790f970dfaa3517b804ef2\",\"name\":\"Steve Tsetsekos\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg\",\"contentUrl\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg\",\"caption\":\"Steve Tsetsekos\"},\"sameAs\":[\"https:\/\/www.fratnow.com\/\"],\"url\":\"https:\/\/autism.fratnow.com\/blog\/author\/fratnow\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/","og_locale":"en_US","og_type":"article","og_title":"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid","og_description":"Discover how FRAAs, the FRAT\u00ae test, and folinic acid offer targeted hope for ASD, PANS\/PANDAS, and more through folate transport correction.","og_url":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/","og_site_name":"fratnow.com","article_publisher":"https:\/\/www.facebook.com\/autismfrat","article_published_time":"2025-05-10T13:00:13+00:00","article_modified_time":"2025-05-10T13:37:04+00:00","og_image":[{"width":730,"height":400,"url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/05\/the-connection-between-fraas-frat-and-folinic-acid-blog-listing-image.webp","type":"image\/webp"}],"author":"Steve Tsetsekos","twitter_card":"summary_large_image","twitter_title":"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid","twitter_description":"Discover how FRAAs, the FRAT\u00ae test, and folinic acid offer targeted hope for ASD, PANS\/PANDAS, and more through folate transport correction.","twitter_image":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/05\/the-connection-between-fraas-frat-and-folinic-acid-blog-listing-image.webp","twitter_creator":"@AutismFrat","twitter_site":"@AutismFrat","twitter_misc":{"Written by":"Steve Tsetsekos","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/#article","isPartOf":{"@id":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/"},"author":{"name":"Steve Tsetsekos","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/f8b6a595b4790f970dfaa3517b804ef2"},"headline":"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid","datePublished":"2025-05-10T13:00:13+00:00","dateModified":"2025-05-10T13:37:04+00:00","mainEntityOfPage":{"@id":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/"},"wordCount":1800,"commentCount":0,"publisher":{"@id":"https:\/\/autism.fratnow.com\/blog\/#organization"},"articleSection":["Neurodiversity &amp; Wellbeing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/","url":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/","name":"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid","isPartOf":{"@id":"https:\/\/autism.fratnow.com\/blog\/#website"},"datePublished":"2025-05-10T13:00:13+00:00","dateModified":"2025-05-10T13:37:04+00:00","breadcrumb":{"@id":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/autism.fratnow.com\/blog\/the-connection-between-fraas-frat-and-folinic-acid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/autism.fratnow.com\/blog\/"},{"@type":"ListItem","position":2,"name":"The Connection Between FRAAs, FRAT\u00ae and Folinic Acid"}]},{"@type":"WebSite","@id":"https:\/\/autism.fratnow.com\/blog\/#website","url":"https:\/\/autism.fratnow.com\/blog\/","name":"fratnow.com","description":"","publisher":{"@id":"https:\/\/autism.fratnow.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/autism.fratnow.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/autism.fratnow.com\/blog\/#organization","name":"fratnow.com","url":"https:\/\/autism.fratnow.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png","contentUrl":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png","width":194,"height":66,"caption":"fratnow.com"},"image":{"@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/autismfrat","https:\/\/twitter.com\/AutismFrat","https:\/\/www.linkedin.com\/company\/88011685\/admin\/","https:\/\/www.instagram.com\/fratautism\/"]},{"@type":"Person","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/f8b6a595b4790f970dfaa3517b804ef2","name":"Steve Tsetsekos","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg","contentUrl":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg","caption":"Steve Tsetsekos"},"sameAs":["https:\/\/www.fratnow.com\/"],"url":"https:\/\/autism.fratnow.com\/blog\/author\/fratnow\/"}]}},"_links":{"self":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/6700"}],"collection":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/comments?post=6700"}],"version-history":[{"count":2,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/6700\/revisions"}],"predecessor-version":[{"id":6703,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/6700\/revisions\/6703"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/media\/6701"}],"wp:attachment":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/media?parent=6700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/categories?post=6700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/tags?post=6700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}